Abstracts for the meeting may be submitted after a delegate pass is confirmed (booked and paid for). You must be a lead or co-author to submit an abstract. You can upload your abstract immediately after paying for your pass, or at a later date up until Monday 31 January by using the link in your confirmation email.
Encore abstracts can be submitted for the meeting but must not have been published online or in print more than 6 months before the submission deadline date of 31 January 2022 ( ie any material published prior to 31 July 2021 must not be submitted).
Bursaries are available to up to 100 early career researchers who are lead authors of abstracts accepted for the 2022 meeting. If you are successful in applying for a bursary then the appropriate amount will be credited back to your card.
Successful abstract submitters may be invited to have their work included in the meeting programme as either short platform talks, or as posters.
It is your responsibility to obtain written consent for the use of patient data, if applicable. An example of a simple consent form can be found here. Give a copy of the consent form to the patient and keep a copy for your own records.
All platforms and posters are planned to be presented in-person. Should circumstances dictate the meeting moves virtually, your abstracts will be presented within that format.
Here is a summary of abstract guidelines and a timeline of events:
• The deadline for abstract submissions is 23.59, Monday 31 January
• The word limit for abstracts is 200 words, excluding title and authors’ details
• Abstract titles should not exceed 15 words
• There is a limit of 10 authors and institutions per abstract
• Abstracts presented elsewhere after 31 July 2021 may be submitted, but this must be declared
• Abstract and bursary notification will be given on Friday 11 March
• Abstract withdrawal deadline Monday 21 March
You will be asked to select a category and topic when you submit your abstract. Select these from the following:
encephalitis (non infective)
motor neurone disease
traumatic brain injury